Regulatory and Compliance Updates news

10 June 2026

dsm-firmenich: FDA approves bemotrizinol (PARSOL® Shield) for U.S. suncare

FDA clears bemotrizinol (PARSOL® Shield), the first new U.S. sunscreen active in 25+ years, enabling broad‑spectrum, photostable formulas with low‑concentration efficacy.
9 June 2026

Lilly gains FDA approval for EBGLYSS every‑eight‑week maintenance dosing

New every‑eight‑week maintenance option offers as few as six injections per year and can be used without mandatory topical therapy from treatment start.
9 June 2026

Takeda: FDA accepts sBLA for IV ENTYVIO in pediatric UC and Crohn’s

FDA accepted an sBLA to extend IV vedolizumab (ENTYVIO) to children aged 2+ with moderately to severely active UC and Crohn’s; PDUFA Q1 2027.
9 June 2026

PureCycle & Innovia Films produce white, cavitated BOPP using PureFive Choice™ recycled PP

White, cavitated BOPP film made with >40% post‑consumer recycled polypropylene showed virgin‑like processing and comparable mechanical, barrier and sealing performance.
9 June 2026

GSK to acquire Nuvalent for $10.6 billion

Includes two late-stage ROS1 and ALK NSCLC inhibitors under FDA review for 2026 decisions, plus a HER2 candidate; expected to be accretive to profit from 2027 and funded by debt and cash.
8 June 2026

Honeywell expands OT Cybersecurity Suite with AI monitoring and secure media controls

Adds five OT security capabilities — AI monitoring, secure media scanning, data diode, Cyber GRC automation and a managed OT SOC — for manufacturing, energy and critical infrastructure.

The right choices in the European chemical industry

Save time with chemXplore Alpha

Learn more

Next →